XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Performance Share Units
Restricted Stock Units
Treasury Shares
Treasury Shares
Performance Share Units
Treasury Shares
Restricted Stock Units
Common stock
Common stock
Performance Share Units
Common stock
Restricted Stock Units
Preferred Shares Issued
Additional Paid-In Capital
Additional Paid-In Capital
Performance Share Units
Additional Paid-In Capital
Restricted Stock Units
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2023       (18,303)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2023             47,269                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2023                   10          
Beginning balance at Dec. 31, 2023 $ 341,297     $ (260,779)     $ 472     $ 0 $ 115,086     $ 560,690 $ (74,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Purchases of treasury stock (in shares)       (208)                      
Purchases of treasury stock (4,139)     $ (4,139)                      
Share-based compensation 2,033                   2,033        
Other [1] (880)                   (880)        
Net income (loss) 33,657                         33,657  
Other comprehensive income (loss), net of taxes (2,542)                           (2,542)
Declaration of dividends (4,762)                         (4,762)  
Treasury Shares, ending balance (in shares) at Mar. 31, 2024       (18,511)                      
Common Shares Issued shares, ending balance (in shares) at Mar. 31, 2024             47,269                
Preferred Shares Issued, ending balance (in shares) at Mar. 31, 2024                   10          
Ending balance at Mar. 31, 2024 364,664     $ (264,918)     $ 472     $ 0 116,239     589,585 (76,714)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2023       (18,303)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2023             47,269                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2023                   10          
Beginning balance at Dec. 31, 2023 341,297     $ (260,779)     $ 472     $ 0 115,086     560,690 (74,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 52,910                            
Other comprehensive income (loss), net of taxes 28,579                            
Treasury Shares, ending balance (in shares) at Sep. 30, 2024       (19,012)                      
Common Shares Issued shares, ending balance (in shares) at Sep. 30, 2024             47,298                
Preferred Shares Issued, ending balance (in shares) at Sep. 30, 2024                   10          
Ending balance at Sep. 30, 2024 400,245     $ (274,977)     $ 472     $ 0 121,003     599,340 (45,593)
Treasury Shares, beginning balance (in shares) at Mar. 31, 2024       (18,511)                      
Common Shares Issued, beginning balance (in shares) at Mar. 31, 2024             47,269                
Preferred Shares Issued, beginning balance (in shares) at Mar. 31, 2024                   10          
Beginning balance at Mar. 31, 2024 364,664     $ (264,918)     $ 472     $ 0 116,239     589,585 (76,714)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Grant of restricted stock awards (in shares)             28                
Grant of restricted stock awards 0                            
Stock option exercises (in shares)             1                
Stock option exercises     $ 0                        
Purchases of treasury stock (in shares)       (274)                      
Purchases of treasury stock (5,254)     $ (5,624)             370        
Share-based compensation 2,186                   2,186        
Net income (loss) 35,416                         35,416  
Other comprehensive income (loss), net of taxes 996                           996
Declaration of dividends (4,771)                         (4,771)  
Treasury Shares, ending balance (in shares) at Jun. 30, 2024       (18,785)                      
Common Shares Issued shares, ending balance (in shares) at Jun. 30, 2024             47,298                
Preferred Shares Issued, ending balance (in shares) at Jun. 30, 2024                   10          
Ending balance at Jun. 30, 2024 393,237     $ (270,542)     $ 472     $ 0 118,795     620,230 (75,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock option exercises (in shares)       (2) [2]     2                
Stock option exercises (1)     $ (55)             54        
Retirement of treasury shares (in shares)       2 [2]     2                
Retirement of treasury shares 0     $ 55             (55)        
Purchases of treasury stock (in shares)       (227)                      
Purchases of treasury stock (4,435)     $ (4,435)                      
Share-based compensation 2,209                   2,209        
Net income (loss) (16,163)                         (16,163)  
Other comprehensive income (loss), net of taxes 30,125                           30,125
Declaration of dividends (4,727)                         (4,727)  
Treasury Shares, ending balance (in shares) at Sep. 30, 2024       (19,012)                      
Common Shares Issued shares, ending balance (in shares) at Sep. 30, 2024             47,298                
Preferred Shares Issued, ending balance (in shares) at Sep. 30, 2024                   10          
Ending balance at Sep. 30, 2024 $ 400,245     $ (274,977)     $ 472     $ 0 121,003     599,340 (45,593)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2024 (19,382)     (19,382)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2024 47,478           47,478                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2024 10                 10          
Beginning balance at Dec. 31, 2024 $ 373,250     $ (282,693)     $ 475     $ 0 121,781     596,853 (63,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Vesting of equity instruments other than options (in shares)         40 [3] 20 [3]   102 52            
Vesting of equity instruments other than options   $ (806) $ (461)   $ (806) $ (461)   $ 1 $ 1     $ (1) $ (1)    
Retirement of treasury shares (in shares)       60 [3]     60                
Retirement of treasury shares 0     $ 1,267     $ (1)       (1,266)        
Share-based compensation 1,362                   1,362        
Net income (loss) 41,439                         41,439  
Other comprehensive income (loss), net of taxes 12,094                           12,094
Declaration of dividends (4,491)                         (4,491)  
Treasury Shares, ending balance (in shares) at Mar. 31, 2025       (19,382)                      
Common Shares Issued shares, ending balance (in shares) at Mar. 31, 2025             47,572                
Preferred Shares Issued, ending balance (in shares) at Mar. 31, 2025                   10          
Ending balance at Mar. 31, 2025 $ 422,387     $ (282,693)     $ 476     $ 0 121,875     633,801 (51,072)
Treasury Shares, beginning balance (in shares) at Dec. 31, 2024 (19,382)     (19,382)                      
Common Shares Issued, beginning balance (in shares) at Dec. 31, 2024 47,478           47,478                
Preferred Shares Issued, beginning balance (in shares) at Dec. 31, 2024 10                 10          
Beginning balance at Dec. 31, 2024 $ 373,250     $ (282,693)     $ 475     $ 0 121,781     596,853 (63,166)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 116,362                            
Other comprehensive income (loss), net of taxes $ 32,411                            
Treasury Shares, ending balance (in shares) at Sep. 30, 2025 (20,016)     (20,016)                      
Common Shares Issued shares, ending balance (in shares) at Sep. 30, 2025 48,064           48,064                
Preferred Shares Issued, ending balance (in shares) at Sep. 30, 2025 10                 10          
Ending balance at Sep. 30, 2025 $ 495,043     $ (298,194)     $ 481     $ 0 124,063     699,448 (30,755)
Treasury Shares, beginning balance (in shares) at Mar. 31, 2025       (19,382)                      
Common Shares Issued, beginning balance (in shares) at Mar. 31, 2025             47,572                
Preferred Shares Issued, beginning balance (in shares) at Mar. 31, 2025                   10          
Beginning balance at Mar. 31, 2025 422,387     $ (282,693)     $ 476     $ 0 121,875     633,801 (51,072)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Grant of restricted stock awards (in shares)             22                
Grant of restricted stock awards 0                            
Stock option exercises (in shares)       (15) [3]     17                
Stock option exercises (23)     $ (404)             381        
Retirement of treasury shares (in shares)       15 [3]     15                
Retirement of treasury shares 0     $ 404             (404)        
Purchases of treasury stock (in shares)       (287)                      
Purchases of treasury stock (7,427)     $ (7,427)                      
Share-based compensation 2,067                   2,067        
Net income (loss) 35,093                         35,093  
Other comprehensive income (loss), net of taxes 10,290                           10,290
Declaration of dividends (4,579)                         (4,579)  
Treasury Shares, ending balance (in shares) at Jun. 30, 2025       (19,669)                      
Common Shares Issued shares, ending balance (in shares) at Jun. 30, 2025             47,596                
Preferred Shares Issued, ending balance (in shares) at Jun. 30, 2025                   10          
Ending balance at Jun. 30, 2025 457,808     $ (290,120)     $ 476     $ 0 123,919     664,315 (40,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Grant of restricted stock awards (in shares)             325                
Grant of restricted stock awards 0           $ 3       (3)        
Stock option exercises (in shares)       (550) [3]     693                
Stock option exercises (2,349)     $ (14,013)     $ 7       11,657        
Retirement of treasury shares (in shares)       550 [3]     550                
Retirement of treasury shares 0     $ 14,013     $ (5)       (14,008)        
Purchases of treasury stock (in shares)       (347)                      
Purchases of treasury stock (8,074)     $ (8,074)                      
Share-based compensation 2,498                   2,498        
Net income (loss) 39,830                         39,830  
Other comprehensive income (loss), net of taxes 10,027                           10,027
Declaration of dividends $ (4,697)                         (4,697)  
Treasury Shares, ending balance (in shares) at Sep. 30, 2025 (20,016)     (20,016)                      
Common Shares Issued shares, ending balance (in shares) at Sep. 30, 2025 48,064           48,064                
Preferred Shares Issued, ending balance (in shares) at Sep. 30, 2025 10                 10          
Ending balance at Sep. 30, 2025 $ 495,043     $ (298,194)     $ 481     $ 0 $ 124,063     $ 699,448 $ (30,755)
[1]
The Other line within Paid-in Capital includes $511 thousand related to cash settlement of certain restricted share units.
[2] All shares acquired represent shares tendered to cover the strike price for options and tax withholdings on the intrinsic value of stock options exercised, restricted stock vested, performance share units vested, or restricted stock units vested. These shares have been cancelled by the Company.
[3] All shares acquired represent shares tendered to cover the strike price for options and tax withholdings on the intrinsic value of stock options exercised, restricted stock vested, performance share units vested, or restricted stock units vested. These shares have been cancelled by the Company.